These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38539499)

  • 21. The Genomic Landscape of PAX5, IKZF1, and CDKN2A/B Alterations in B-Cell Precursor Acute Lymphoblastic Leukemia.
    Ou Z; Sherer M; Casey J; Bakos HA; Vitullo K; Hu J; Friehling E; Gollin SM; Surti U; Yatsenko SA
    Cytogenet Genome Res; 2016; 150(3-4):242-252. PubMed ID: 28214896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mutational spectrum and its prognostic significance in childhood acute lymphoblastic leukemia based on next-generation sequencing technology].
    Zheng YZ; Zheng H; Chen ZS; Hua XL; Le SH; Li J; Hu JD
    Zhonghua Xue Ye Xue Za Zhi; 2022 Jan; 43(1):19-25. PubMed ID: 35231988
    [No Abstract]   [Full Text] [Related]  

  • 23. Prognostic significance of copy number alterations detected by multi-link probe amplification of multiple genes in adult acute lymphoblastic leukemia.
    Fang Q; Yuan T; Li Y; Feng J; Gong X; Li Q; Zhao X; Liu K; Tang K; Tian Z; Zhang Q; Wang Y; Liu B; Wang M; Ru K; Wang J; Mi Y
    Oncol Lett; 2018 Apr; 15(4):5359-5367. PubMed ID: 29552179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001.
    Tran TH; Langlois S; Meloche C; Caron M; Saint-Onge P; Rouette A; Bataille AR; Jimenez-Cortes C; Sontag T; Bittencourt H; Laverdière C; Lavallée VP; Leclerc JM; Cole PD; Gennarini LM; Kahn JM; Kelly KM; Michon B; Santiago R; Stevenson KE; Welch JJG; Schroeder KM; Koch V; Cellot S; Silverman LB; Sinnett D
    Blood Adv; 2022 Feb; 6(4):1329-1341. PubMed ID: 34933343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PAX5-KIAA1549L: a novel fusion gene in a case of pediatric B-cell precursor acute lymphoblastic leukemia.
    Anderl S; König M; Attarbaschi A; Strehl S
    Mol Cytogenet; 2015; 8():48. PubMed ID: 26157485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PAX5-AUTS2: a recurrent fusion gene in childhood B-cell precursor acute lymphoblastic leukemia.
    Denk D; Nebral K; Bradtke J; Pass G; Möricke A; Attarbaschi A; Strehl S
    Leuk Res; 2012 Aug; 36(8):e178-81. PubMed ID: 22578776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features.
    Schwab CJ; Chilton L; Morrison H; Jones L; Al-Shehhi H; Erhorn A; Russell LJ; Moorman AV; Harrison CJ
    Haematologica; 2013 Jul; 98(7):1081-8. PubMed ID: 23508010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk assessment of
    Khalid A; Aslam S; Ahmed M; Hasnain S; Aslam A
    PeerJ; 2019; 7():e7195. PubMed ID: 31565544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.
    Krentz S; Hof J; Mendioroz A; Vaggopoulou R; Dörge P; Lottaz C; Engelmann JC; Groeneveld TW; Körner G; Seeger K; Hagemeier C; Henze G; Eckert C; von Stackelberg A; Kirschner-Schwabe R
    Leukemia; 2013 Feb; 27(2):295-304. PubMed ID: 22699455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic Determinants of Outcome in Acute Lymphoblastic Leukemia.
    Chang TC; Chen W; Qu C; Cheng Z; Hedges D; Elsayed A; Pounds SB; Shago M; Rabin KR; Raetz EA; Devidas M; Cheng C; Angiolillo A; Baviskar P; Borowitz M; Burke MJ; Carroll A; Carroll WL; Chen IM; Harvey R; Heerema N; Iacobucci I; Wang JR; Jeha S; Larsen E; Mattano L; Maloney K; Pui CH; Ramirez NC; Salzer W; Willman C; Winick N; Wood B; Hunger SP; Wu G; Mullighan CG; Loh ML
    J Clin Oncol; 2024 Aug; ():JCO2302238. PubMed ID: 39121442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common clonal origin of an acute B-lymphoblastic leukemia and a Langerhans' cell sarcoma: evidence for hematopoietic plasticity.
    Ratei R; Hummel M; Anagnostopoulos I; Jähne D; Arnold R; Dörken B; Mathas S; Benter T; Dudeck O; Ludwig WD; Stein H
    Haematologica; 2010 Sep; 95(9):1461-6. PubMed ID: 20421277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.
    Hof J; Krentz S; van Schewick C; Körner G; Shalapour S; Rhein P; Karawajew L; Ludwig WD; Seeger K; Henze G; von Stackelberg A; Hagemeier C; Eckert C; Kirschner-Schwabe R
    J Clin Oncol; 2011 Aug; 29(23):3185-93. PubMed ID: 21747090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.
    Volejnikova J; Mejstrikova E; Dörge P; Meissner B; Zimmermannova O; Svojgr K; Stanulla M; Cario G; Schrappe M; Stary J; Hrusak O; Trka J; Fronkova E
    Pediatr Blood Cancer; 2013 Mar; 60(3):420-7. PubMed ID: 22997141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
    Cario G; Rhein P; Mitlöhner R; Zimmermann M; Bandapalli OR; Romey R; Moericke A; Ludwig WD; Ratei R; Muckenthaler MU; Kulozik AE; Schrappe M; Stanulla M; Karawajew L
    Haematologica; 2014 Jan; 99(1):103-10. PubMed ID: 23911702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood.
    Schmäh J; Fedders B; Panzer-Grümayer R; Fischer S; Zimmermann M; Dagdan E; Bens S; Schewe D; Moericke A; Alten J; Bleckmann K; Siebert R; Schrappe M; Stanulla M; Cario G
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28371317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group.
    Biondi A; Valsecchi MG; Seriu T; D'Aniello E; Willemse MJ; Fasching K; Pannunzio A; Gadner H; Schrappe M; Kamps WA; Bartram CR; van Dongen JJ; Panzer-Grümayer ER
    Leukemia; 2000 Nov; 14(11):1939-43. PubMed ID: 11069029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia.
    Yu CH; Lin TK; Jou ST; Lin CY; Lin KH; Lu MY; Chen SH; Cheng CN; Wu KH; Wang SC; Chang HH; Li MJ; Ni YL; Su YN; Lin DT; Chen HY; Harrison CJ; Hung CC; Lin SW; Yang YL
    Sci Rep; 2020 Jul; 10(1):11501. PubMed ID: 32661308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAX5 alterations in an infant case of KMT2A-rearranged leukemia with lineage switch.
    Nakajima K; Kubota H; Kato I; Isobe K; Ueno H; Kozuki K; Tanaka K; Kawabata N; Mikami T; Tamefusa K; Nishiuchi R; Saida S; Umeda K; Hiramatsu H; Adachi S; Takita J
    Cancer Sci; 2022 Jul; 113(7):2472-2476. PubMed ID: 35467057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PAX5 fusion genes in acute lymphoblastic leukemia: A literature review.
    Fouad FM; Eid JI
    Medicine (Baltimore); 2023 May; 102(20):e33836. PubMed ID: 37335685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes.
    Tomoyasu C; Imamura T; Tomii T; Yano M; Asai D; Goto H; Shimada A; Sanada M; Iwamoto S; Takita J; Minegishi M; Inukai T; Sugita K; Hosoi H
    Int J Hematol; 2018 Sep; 108(3):312-318. PubMed ID: 29786757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.